Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

Journal of General Virology

Volumn 79, Issue 1, 1998, Pages 83-90

  Hanke, T ^a   Blanchard, T J ^b   Schneider, J ^a   Ogg, G S ^a   Tan, R ^a   Becker, M ^b   Gilbert, S C ^c   Hill, A V S ^a   Smith, G L ^b   McMichael, A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SPLEEN CELL; T LYMPHOCYTE; VACCINATION;

ANIMALIA; ANKARA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; MURINAE; RNA VIRUSES; VACCINIA; VACCINIA VIRUS;

EID: 15144345621     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-1-83     Document Type: Article

References (39)

1. Altenburger, W., Suter, C. P. & Altenburger, J. (1989). Partial deletion of the human host range gene in the attenuated vaccinia virus MVA. Archives of Virology 105, 15-27.
2. Carmichael, A., Jin, X., Sissons, P. & Borysiewicz, L. (1993). Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. Journal of Experimental Medicine 177, 249-256.
3. Carroll, M. W. & Moss, B. (1995). E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses. Biotechniques 19, 352-356.
4. Carroll, M. W., Overwijk, W. W., Chamberlain, R. S., Rosenberg, S. A., Moss, B. & Restifo, N. P. (1997). Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine model. Vaccine 15, 387-394.
5. Chakrabarti, S., Brechung, K. & Moss, B. (1985). Vaccinia virus expression vector: co-expression of beta-galactosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5, 3403-3409.
6. Gilbert, S. G., Plebanski, M., Harris, S. J., Allsopp, C. E. M., Thomas, R., Layton, G. T. & Hill, A. V. S. (1997). A protein particle vaccine containing multiple malaria epitope. Nature Biotechnology (in press).
7. Hanke, T., Szawlowski, P. & Randall, R. E. (1992). Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. Journal of General Virology 73, 653-660.
8. Hanke, T., Schneider, J., Gilbert, S. G., Hill, A. V. S. & McMichael, A. (1997a). DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice. Vaccine (in press).
9. Hanke, T., Blanchard, T. J., Schneider, J., Hannan, C. M., Becker, M., Gilbert, S. G., Hill, A. V. S., Smith, G. L. & McMichael, A. (1997b). Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (in press).
10. Hill, A. V., Allsopp, C. E., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J. & Greenwood, B. M. (1991). Common west African HLA antigens are associated with protection from severe malaria. Nature 352, 595-600.
11. Kalams, S. A., Johnson, R. P., Trocha, A. K., Dynan, M. J., Ngo, H. S., D'Aquila, R. T., Kurnick, J. T. & Walker, B. D. (1994). Longitudinal analysis of TCR gene usage by HIV-1 envelope-specific CTL clones reveals a limited TCR repertoire. Journal of Experimental Medicine 179, 1261-1271.
12. Lalvani, A., Aidoo, M., Allsopp, C. E., Plebanski, M., Whittle, H. C. & Hill, A. V. (1994). An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum. Research in Immunology 145, 461-468.
13. Mackett, M., Smith, G. L. & Moss, B. (1984). General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49, 857-864.
14. McMichael, A. (1992). Cytotoxic T lymphocytes and immune surveillance. Cancer Survey 13, 5-21.
15. Mayr, A., Hochstein-Mintzel, V. & Stickl, H. (1975). Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA. Infection 105, 6-14.
16. Mayr, A., Stickl, H., Muller, H. K., Danner, K. & Singer, H. (1978). Der Pockenimpfstamm MVA: Marker, genetische Struktur, Erfahrungen mit der parenteralen Schutzimpfung und Verhalten im abwehrgeschwachten Organismus. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankkeiten und Hygiene, Erste Abteilung Originale, Reihe B 167, 375-390.
17. Meyer, H., Sutler, G. & Mayr, A. (1991). Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. Journal of General Virology 72, 1031-1038.
18. Miyahira, Y., Murata, K., Rodriguez, D., Esteban, M., Rodrigues, M. M. & Zavala, F. (1995). Quantification of antigen specific CD8+ T cells using an ELISPOT assay. Journal of Immunological Methods 181, 45-54.
19. Oldstone, M. B., Tishon, A., Eddleston, M., McKee, T. & Whitton, J. L. (1993). Vaccination to prevent persistent viral infection. Journal of Virology 67, 4372-4378.
20. Plata, F., Autran, B., Martins, L. P., Wain-Hobson, S., Raphael, M., Mayaud, C., Denis, M., Guillon, J. M. & Debre, P. (1987). AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328, 348-351.
21. Rabinovich, N. R., Mclnnes, P., Klein, D. L. & Hall, B. F. (1994). Vaccine technologies - views to the future. Science 265, 1401-1404.
22. Ria, F., Chan, B. M., Scherer, M. T., Smith, J. A. & Gefter, M. L. (1990). Immunological activity of covalently linked T-cell epitopes. Nature 343, 381-383.
23. Romero, P., Maryanski, J. L., Corradin, G., Nussenzweig, R. S., Nussenzweig, V. & Zavala, F. (1989). Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341, 323-326.
24. Rowland-Jones, S. L., Nixon, D. F., Aldhous, M. C., Gotch, F., Ariyoshi, K., Hallam, N., Kroll, J. S., Froebel, K. & McMichael, A. (1993). HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341, 860-861.
25. Rowland-Jones, S., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F., McAdam, S., Whitby, D., Sabally, S., Gallimore, A., Corrah, T., Takiguchi, M., Schultz, T., McMichael, A. & Whittle, H. (1995). HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Medicine 1, 59-64.
26. Sad, S., Kagi, D. & Mosmann, T. R. (1996). Perform and Fas killing by CD8+ T cells limits their cytokine synthesis and proliferation. Journal of Experimental Medicine 184, 1543-1547.
27. Sidney, J., Grey, H. M., Kubo, R. T. & Sette, A. (1996). Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunology Today 17, 261-266.
28. Sutter, G. & Moss, B. (1992). Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proceedings of the National Academy of Sciences, USA 89, 10847-10851.
29. Sutter, G., Wyatt, L. S., Foley, P. L., Bennink, J. R. & Moss, B. (1994). A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 12, 1032-1040.
30. Takahashi, H., Nakagawa, Y., Yokomuro, K. & Berzofsky, J. A. (1993). Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. International Immunology 5, 849-857.
31. Thomson, S. A., Khanna, R., Gardner, J., Burrows, S. R., Coupar, B., Moss, D. J. & Suhrbier, A. (1995). Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. Proceedings of the National Academy of Sciences, USA 92, 5845-5849.
32. Thomson, S. A., Elliott, S. L., Sherritt, M. A., Sproat, K. W., Coupar, B. E. H., Scalzo, A. A., Forbes, C. A., Ladhams, A. M., Mo, X. Y., Tripp, R. A., Doherty, P. C., Moss, D. J. & Suhribier, A. (1996). Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. Journal of Immunology 157, 822-826.
33. Townsend, A., Bastin, J., Gould, K., Brownlee, G., Andrew, M., Coupar, B., Boyle, D., Chan, S. & Smith, G. (1988). Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. Journal of Experimental Medicine 168, 1211-1224.
34. Valitutti, S., Muller, S., Dessing, M. & Lanzavecchia, A. (1996). Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. Journal of Experimental Medicine 183, 1917-1921.
35. Walker, B. D., Chakrabarti, S., Moss, B., Paradis, T. J., Flynn, T., Durno, A. G., Blumberg, R. S., Kaplan, J. C., Hirsch, M. S. & Schooley, R. T. (1987). HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345-348.
36. d histocompatibility antigens. Journal of Experimental Medicine 161, 356-365.
37. Whitton, J. L., Sheng, N., Oldstone, M. B. & McKee, T. A. (1993). A 'string-of-beads' vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. Journal of Virology 67, 348-352.
38. Yasutomi, Y., McAdam, S. N., Boyson, J. E., Watkins, D. I. & Letvin, N. L. (1995). An MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope on rhesus monkeys. Journal of Immunology 154, 2516-2522.
39. Zinkernagel, R. M. & Doherty, P. C. (1975). H-2 compatibility requirement for T cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Journal of Experimental Medicine 141, 1427-1436.